# ABACAVIR SULFATE; LAMIVUDINE
> **NDA202381** · New Drug Application · Sponsor: MYLAN LABS · Approved 2012-01-31
## Drug
- **FDA Application Number:** NDA202381
- **Application type:** New Drug Application
- **Brand name:** ABACAVIR SULFATE; LAMIVUDINE
- **Generic name:** Abacavir Sulfate
- **Active ingredients:** ABACAVIR SULFATE; LAMIVUDINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** MYLAN LABS
- **First approval:** 2012-01-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202381)
---
*MORVS · CC0 1.0*